Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Mixed Start To Week (And End To Month) As Investors Linger On Covid-19 Headlines

Published 30/11/2020, 09:15
Updated 21/10/2020, 09:15

It was a mixed bag on Monday morning, with no definitive direction for trading as the markets float between news items.

Without any major vaccine updates – though the UK is preparing to approve the Pfizer/BioNTech preparation in the next few days, before the FDA in the US even meet to discuss it on December 10th – Brexit breakthroughs or particularly positive covid-19 headlines, it was hard for traders to glom onto anything concrete after the bell.

That led to an inconsistent board, with the FTSE adding 0.1%, but remaining short of 6,400, while the DAX dropped 0.2% and the CAC fell half a percent.

The US open could create a more decisive mood on the markets – the Dow Jones is heading for an 180 point decline, one that would force the index back under 29,750, after it failed to close above 30,000 at the end of last week.

This as the States just saw its 27th consecutive day of at least 100,000 new daily cases, while November’s monthly total crossed 4 million, more than double the additions made in October.

Lacking any other distractions, investors are forced to consider the latest covid-19 developments, perhaps explaining the at-best muted tone of trading at the start of the week.

It’s also been an exhausting, exhilarating month for investors – they may simply want to tie up a few loose ends before heading into the year’s closing gambit.

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.